DOSAGE AND ADMINISTRATION
Dosing Considerations
-
•RELENZA is for administration to the respiratory tract by oral inhalation only, using the DISKHALER® device provided [see Warnings and Precautions].
-
•The 10-mg dose is provided by 2 inhalations (one 5-mg blister per inhalation).
-
•Patients should be instructed in the use of the delivery system. Instructions should include a demonstration whenever possible. If RELENZA is prescribed for children, it should be used only under adult supervision and instruction, and the supervising adult should first be instructed by a healthcare professional [see Patient Counseling Information].
-
•Patients scheduled to use an inhaled bronchodilator at the same time as RELENZA should use their bronchodilator before taking RELENZA [see Patient Counseling Information].
Treatment of Influenza
-
•The recommended dose of RELENZA for treatment of influenza in adults and pediatric patients aged 7 years and older is 10 mg twice daily (approximately 12 hours apart) for 5 days.
-
•Two doses should be taken on the first day of treatment whenever possible provided there is at least 2 hours between doses.
-
•On subsequent days, doses should be about 12 hours apart (e.g., morning and evening) at approximately the same time each day.
-
•The safety and efficacy of repeated treatment courses have not been studied.
Prophylaxis of Influenza
Household Setting:
-
•The recommended dose of RELENZA for prophylaxis of influenza in adults and pediatric patients aged 5 years and older in a household setting is 10 mg once daily for 10 days.
-
•The dose should be administered at approximately the same time each day.
-
•There are no data on the effectiveness of prophylaxis with RELENZA in a household setting when initiated more than 1.5 days after the onset of signs or symptoms in the index case.
Community Outbreaks:
-
•The recommended dose of RELENZA for prophylaxis of influenza in adults and adolescents in a community setting is 10 mg once daily for 28 days.
-
•The dose should be administered at approximately the same time each day.
-
•There are no data on the effectiveness of prophylaxis with RELENZA in a community outbreak when initiated more than 5 days after the outbreak was identified in the community.
-
•The safety and effectiveness of prophylaxis with RELENZA have not been evaluated for longer than 28 days’ duration.
DOSAGE FORMS AND STRENGTHS
Blister for oral inhalation: 5 mg. Four 5-mg blisters of powder on a ROTADISK® for oral inhalation via DISKHALER. Packaged in carton containing 5 ROTADISKs (total of 10 doses) and 1 DISKHALER inhalation device [see How Supplied/Storage and Handling].
|